These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6174878)

  • 1. A survey of substance P, somatostatin, and neurotensin levels in aging in the rat and human central nervous system.
    Buck SH; Deshmukh PP; Burks TF; Yamamura HI
    Neurobiol Aging; 1981; 2(4):257-64. PubMed ID: 6174878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study.
    Jessell TM; Emson PC; Paxinos G; Cuello AC
    Brain Res; 1978 Sep; 152(3):487-98. PubMed ID: 356929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of substance P, somatostatin and neurotensin in the human hypothalamus.
    Langevin H; Emson PC
    Brain Res; 1982 Aug; 246(1):65-9. PubMed ID: 6181851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular forms of somatostatin, substance P and neurotensin in fresh human cerebral cortex.
    Bateman DE; McDermott JR; Smith AI; Biggins JA; Edwardson JA
    Regul Pept; 1986 May; 14(3):211-6. PubMed ID: 2425398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotensin in projection neurons of the striatum and nucleus accumbens, with reference to coexistence with enkephalin and GABA: an immunohistochemical study in the cat.
    Sugimoto T; Mizuno N
    J Comp Neurol; 1987 Mar; 257(3):383-95. PubMed ID: 2435769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kainic acid induced seizures: changes in somatostatin, substance P and neurotensin.
    Sperk G; Wieser R; Widmann R; Singer EA
    Neuroscience; 1986 Apr; 17(4):1117-26. PubMed ID: 2423920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes of neuropeptides in the patient with progressive supranuclear palsy--distribution of substance P, somatostatin and neurotensin in the brain].
    Fujiyoshi K; Suga H; Nagata H; Nakamura S; Kameyama M
    Rinsho Shinkeigaku; 1984 Jan; 24(1):17-22. PubMed ID: 6205807
    [No Abstract]   [Full Text] [Related]  

  • 8. Somatostatin is increased in the basal ganglia in Huntington disease.
    Aronin N; Cooper PE; Lorenz LJ; Bird ED; Sagar SM; Leeman SE; Martin JB
    Ann Neurol; 1983 May; 13(5):519-26. PubMed ID: 6191621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatographic characterization of neuropeptides in post mortem human brain.
    Biggins JA; McDermott JR; Smith AI; Candy JM; Perry RH; Bateman DE; Edwardson JA
    J Neurol Sci; 1984 Oct; 66(1):47-58. PubMed ID: 6084049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
    Marshall PE; Landis DM; Zalneraitis EL
    Brain Res; 1983 Dec; 289(1-2):11-26. PubMed ID: 6198034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of neurotensin-like immunoreactivity in human basal ganglia: increased neurotensin levels in substantia nigra in Parkinson's disease.
    Fernandez A; Jenner P; Marsden CD; De Ceballos ML
    Peptides; 1995; 16(2):339-46. PubMed ID: 7784265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotensin receptor binding levels in basal ganglia are not altered in Huntington's chorea or schizophrenia.
    Palacios JM; Chinaglia G; Rigo M; Ulrich J; Probst A
    Synapse; 1991 Feb; 7(2):114-22. PubMed ID: 1672780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional distribution of bombesin and seven other regulatory peptides in the human brain.
    Ghatei MA; Bloom SR; Langevin H; McGregor GP; Lee YC; Adrian TE; O'Shaughnessy DJ; Blank MA; Uttenthal LO
    Brain Res; 1984 Feb; 293(1):101-9. PubMed ID: 6200182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease.
    Buck SH; Burks TF; Brown MR; Yamamura HI
    Brain Res; 1981 Mar; 209(2):464-9. PubMed ID: 6164436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease.
    Beal MF; Mazurek MF; Ellison DW; Swartz KJ; McGarvey U; Bird ED; Martin JB
    Ann Neurol; 1988 Jun; 23(6):562-9. PubMed ID: 2900622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal polypeptide-, neurotensin-, substance P-, gastrin-releasing peptide-, calcitonin-, calcitonin gene related peptide-, and somatostatin-like immunoreactivities in human parathyroid glands.
    Weber CJ; O'Dorisio TM; Howe B; D'Agati V; Ward L; Russell J; Feind CR
    Surgery; 1991 Dec; 110(6):1078-85. PubMed ID: 1720902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical evidence for a neurotensin striatonigral pathway in the rat brain.
    Castel MN; Morino P; Frey P; Terenius L; Hökfelt T
    Neuroscience; 1993 Aug; 55(3):833-47. PubMed ID: 8105419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in neurotensin and substance P following nicotine self-administration in rats.
    Pittenger ST; Swalve N; Chou S; Smith MD; Hoonakker AJ; Pudiak CM; Fleckenstein AE; Hanson GR; Bevins RA
    Synapse; 2016 Aug; 70(8):336-46. PubMed ID: 27074301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of neurotensin-containing fibers in the frontal cortex of the macaque monkey.
    Satoh K; Matsumura H
    J Comp Neurol; 1990 Aug; 298(2):215-23. PubMed ID: 1698832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic regulatory peptide disturbances in the spontaneously obese JCR: LA-corpulent rat.
    Williams G; Cardoso HM; Domin J; Ghatei MA; Russell JC; Bloom SR
    Diabetes Res; 1990 Sep; 15(1):1-7. PubMed ID: 1720364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.